MTN 023/ IPM 030
Status:Completed
Phase:II
Principal Investigator(s):Kathleen Squires, Katherine Bunge
Objective:Study to assess the safety of dapivirine vaginal ring (inserted every 4 weeks) in HIV-negative adolescent females.
*Closed to follow up as of 7/5/16*
Last updated May 16, 2021
Prevention Option(s):Microbicides
Study Design:Controlled, Double-blind, Randomized
Arms and Assigned Interventions
Description
Mode of DeliveryRing
ARMsExperimental
Official Code:
NCT02028338
Trial Sponsors:
ATN, IPM, MTN, NIAID (DAIDS-ES: 11927), NICHD
Start Date
End Date
March 31, 2014
July 1, 2016
Enrollment:96
Age range:
15 Years ↔
17 Years
Population:Cisgender Women